Tags

Type your tag names separated by a space and hit enter

Vaccinations and malaria prophylaxis for long-term travellers travelling from Greece: a prospective, questionnaire-based analysis.
Travel Med Infect Dis. 2014 Nov-Dec; 12(6 Pt B):764-70.TM

Abstract

The purpose of this prospective, questionnaire-based study is to assess pre-travel vaccinations and malaria prophylaxis for long-term travellers who receive pre-travel advice in Greece. A total of 4721 travellers were studied from January 1, 2009 through December 31, 2012. Travellers sought pre-travel advice at a mean of 19.7 days (range: 0-349 days) before departure. Long-term travellers (≥ 1 month) accounted for 2205 (46.7%) of all travellers. Long-term travellers had a mean age of 34.5 years. The majority of them were men (79.8%). In terms of destinations, 84% were visiting malaria-endemic countries and sub-Saharan Africa was the most common destination (17.7%). Most long-term travellers pursued trips for work purposes (70%), visited urban areas (79.6%) and stayed in hotels (29.2%). Yellow fever, typhoid fever, hepatitis A and tetanus/diphtheria vaccines were administered to 1647 (74.7%), 741 (33.6%), 652 (29.5%), and 589 (26.7%) travellers, respectively. Yellow fever vaccine was administered to 339 (87%) and 132 (71%) of long-term travellers to sub-Saharan Africa and South America respectively, whereas typhoid vaccine to 119 (90.8%) and 330 (84.6%) of those travelling to the Indian subcontinent and sub-Saharan Africa respectively. Rabies vaccine was administered to 14 (0.6%) of them. Malaria prophylaxis was recommended to 446 (20%) of long-term travellers. Mefloquine was the most commonly (49%) prescribed agent, and was prescribed to 26.7% of long-term travellers to sub-Sahara Africa. In conclusion, this study revealed that recommendations for vaccine and malaria prophylaxis for long-term travellers to developing countries should be more selective, based on the assessment of all travellers' and travel characteristics, in order to provide adequate pre-travel preparation for this high risk group of travellers. More focused studies are suggested in order to understand the particular needs of long-term travellers. Increasing awareness of travellers and travel health consultants is very important.

Authors+Show Affiliations

Travel Medicine Office.Travel Medicine Office.Travel Medicine Office.Travel Medicine Office.Department for Interventions in Health Care Facilities, Hellenic Center for Disease Control and Prevention, Athens, Greece.Department for Interventions in Health Care Facilities, Hellenic Center for Disease Control and Prevention, Athens, Greece. Electronic address: helen-maltezou@ath.forthnet.gr.

Pub Type(s)

Journal Article

Language

eng

PubMed ID

24957561

Citation

Pavli, Androula, et al. "Vaccinations and Malaria Prophylaxis for Long-term Travellers Travelling From Greece: a Prospective, Questionnaire-based Analysis." Travel Medicine and Infectious Disease, vol. 12, no. 6 Pt B, 2014, pp. 764-70.
Pavli A, Smeti P, Spilioti A, et al. Vaccinations and malaria prophylaxis for long-term travellers travelling from Greece: a prospective, questionnaire-based analysis. Travel Med Infect Dis. 2014;12(6 Pt B):764-70.
Pavli, A., Smeti, P., Spilioti, A., Silvestros, C., Katerelos, P., & Maltezou, H. C. (2014). Vaccinations and malaria prophylaxis for long-term travellers travelling from Greece: a prospective, questionnaire-based analysis. Travel Medicine and Infectious Disease, 12(6 Pt B), 764-70. https://doi.org/10.1016/j.tmaid.2014.05.003
Pavli A, et al. Vaccinations and Malaria Prophylaxis for Long-term Travellers Travelling From Greece: a Prospective, Questionnaire-based Analysis. Travel Med Infect Dis. 2014 Nov-Dec;12(6 Pt B):764-70. PubMed PMID: 24957561.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - Vaccinations and malaria prophylaxis for long-term travellers travelling from Greece: a prospective, questionnaire-based analysis. AU - Pavli,Androula, AU - Smeti,Paraskevi, AU - Spilioti,Athina, AU - Silvestros,Chrysovalantis, AU - Katerelos,Panagiotis, AU - Maltezou,Helena C, Y1 - 2014/05/23/ PY - 2013/02/16/received PY - 2014/03/14/revised PY - 2014/05/13/accepted PY - 2014/6/25/entrez PY - 2014/6/25/pubmed PY - 2015/9/9/medline KW - Long-term travellers KW - Malaria KW - Prophylaxis KW - Typhoid KW - Vaccine SP - 764 EP - 70 JF - Travel medicine and infectious disease JO - Travel Med Infect Dis VL - 12 IS - 6 Pt B N2 - The purpose of this prospective, questionnaire-based study is to assess pre-travel vaccinations and malaria prophylaxis for long-term travellers who receive pre-travel advice in Greece. A total of 4721 travellers were studied from January 1, 2009 through December 31, 2012. Travellers sought pre-travel advice at a mean of 19.7 days (range: 0-349 days) before departure. Long-term travellers (≥ 1 month) accounted for 2205 (46.7%) of all travellers. Long-term travellers had a mean age of 34.5 years. The majority of them were men (79.8%). In terms of destinations, 84% were visiting malaria-endemic countries and sub-Saharan Africa was the most common destination (17.7%). Most long-term travellers pursued trips for work purposes (70%), visited urban areas (79.6%) and stayed in hotels (29.2%). Yellow fever, typhoid fever, hepatitis A and tetanus/diphtheria vaccines were administered to 1647 (74.7%), 741 (33.6%), 652 (29.5%), and 589 (26.7%) travellers, respectively. Yellow fever vaccine was administered to 339 (87%) and 132 (71%) of long-term travellers to sub-Saharan Africa and South America respectively, whereas typhoid vaccine to 119 (90.8%) and 330 (84.6%) of those travelling to the Indian subcontinent and sub-Saharan Africa respectively. Rabies vaccine was administered to 14 (0.6%) of them. Malaria prophylaxis was recommended to 446 (20%) of long-term travellers. Mefloquine was the most commonly (49%) prescribed agent, and was prescribed to 26.7% of long-term travellers to sub-Sahara Africa. In conclusion, this study revealed that recommendations for vaccine and malaria prophylaxis for long-term travellers to developing countries should be more selective, based on the assessment of all travellers' and travel characteristics, in order to provide adequate pre-travel preparation for this high risk group of travellers. More focused studies are suggested in order to understand the particular needs of long-term travellers. Increasing awareness of travellers and travel health consultants is very important. SN - 1873-0442 UR - https://www.unboundmedicine.com/medline/citation/24957561/Vaccinations_and_malaria_prophylaxis_for_long_term_travellers_travelling_from_Greece:_a_prospective_questionnaire_based_analysis_ L2 - https://linkinghub.elsevier.com/retrieve/pii/S1477-8939(14)00111-2 DB - PRIME DP - Unbound Medicine ER -